Table 1.
Clinical characteristics of study patients with COVID-19.
| Patient Characteristics (n = 523) | N (%) | Patient Characteristics (n = 523) | N (%) |
|---|---|---|---|
| Age (mean ± SD) | 56.7 ± 16.0 | Coinfections | 22 (4.0) |
| Gender (female) | 214 (40.9) | Bacterial | 16 (72.7) |
| Vaccinated | 132 (25.2) | UTI | 10 (45.4) |
| LOS (median, IQR) | 9 (5) | SSI | 3 (13.6) |
| Clostridium difficile | 2 (9.0) | ||
| Comorbidities | 325 (62.1) | Syphilis | 1 (4.5) |
| Hypertension | 227 (43.4) | Viral/Fungal | 6 (27.2) |
| Obesity | 138 (26.4) | Primary EBV infection | 1 (4.5) |
| Diabetes | 70 (13.4) | Hepatitis B | 1(4.5) |
| Atrial fibrillation | 40 (7.6) | CMV | 1 (4.5) |
| Coronary heart disease | 39 (7.5) | Herpes zoster | 1(4.5) |
| Solid Tumour | 42 (8.0) | Candidiasis | 1 (4.5) |
| COPD | 11 (26.2) | Pulmonary aspergillosis | 1(4.5) |
| Connective Tissue Disease | 31 (5.9) | ||
| Neurological disease | 30 (5.7) | Outcome | |
| Leukaemia/Lymphoma | 23 (4.4) | Recovered | 476 (91.0) |
| Cardiomyopathy | 20 (3.8) | Transferred to ICU | 20 (3.8) |
| Paralysis | 19 (3.6) | Transferred to another hospital | 19 (3.6) |
| Hashimoto thyroiditis | 15 (2.9) | Died | 3 (0.6) |
| Liver disease | 10 (1.9) | Discharged at personal request | 5 (1.0) |
| Chronic kidney disease | 10 (1.9) | ||
| Congestive heart failure | 9 (1.7) | ||
| Dementia | 8 (1.5) | ||
| HIV | 6 (1.1) | ||
| Peptic ulcer disease | 4 (0.8) |
SD: standard deviation. LOS: length of stay; IQR: interquartile range; COPD: Chronic obstructive pulmonary disease; HIV: human immunodeficiency virus; UTI: urinary tract infection; SSI: skin and soft tissue infection; EBV: Epstein-Barr virus; CMV: cytomegalovirus; ICU: intensive care unit.